Compare CRDL & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDL | GOAI |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | Canada | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.1M | 150.5M |
| IPO Year | 2017 | N/A |
| Metric | CRDL | GOAI |
|---|---|---|
| Price | $1.31 | $3.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 653.6K | 59.1K |
| Earning Date | 05-14-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $2.75 |
| 52 Week High | $1.71 | $6.67 |
| Indicator | CRDL | GOAI |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 43.75 |
| Support Level | $0.95 | $3.48 |
| Resistance Level | $1.43 | $4.36 |
| Average True Range (ATR) | 0.10 | 0.35 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 12.50 | 13.75 |
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.